Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSPO | P30536 | 1/20 | 0.37 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.33 |
| ▸ | PTGES | O14684 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.30 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.30 |
| ▸ | FLT3 | P36888 | 1/20 | 0.30 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.30 |
| ▸ | PGR | P06401 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21710701 | 0.95 | TSPO (0.34) | TSPONPY5RPTGESCYP1A2CYP2A6 | |
| SCHEMBL22858283 | 0.89 | TSPO (0.40) | TSPONPY5RPTGESKDM4EMAPT | |
| SCHEMBL21717382 | 0.89 | TSPO (0.40) | TSPONPY5RPTGESKDM4EMAPT | |
| SCHEMBL25965152 | 0.87 | TSPO (0.38) | TSPONPY5RPTGESKDM4EMAPT | |
| SCHEMBL22679275 | 0.86 | TSPO (0.39) | TSPONPY5RPTGESKDM4EMAOB | |
| SCHEMBL21717832 | 0.86 | TSPO (0.39) | TSPONPY5RPTGESKDM4EMAOB | |
| SCHEMBL22858132 | 0.85 | KDM4E (0.36) | TSPONPY5RPTGESKDM4EMAPT | |
| SCHEMBL22679281 | 0.85 | PTGES (0.35) | TSPONPY5RPTGESCYP1A2CYP2A6 | |
| SCHEMBL21710576 | 0.84 | TSPO (0.38) | TSPONPY5RKDM4EMAPTMAOB | |
| SCHEMBL21717841 | 0.84 | TSPO (0.38) | TSPONPY5RPTGESKDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11723272-B2 | Organic electroluminescence element and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2023-08-08 | — | — | US | disclosed |
| US-11723272-B2 | Organic electroluminescence element and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2023-08-08 | — | — | US | disclosed |
| US-20210005825-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2021-01-07 | — | — | US | disclosed |
| US-20200052225-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2020-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200052225-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | LEF1, L1CAM, ESR2 | TSPO 1263/4885NPY5R 3775/4885PTGES 2858/4885 |
| US-20210005825-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | OR51E2, CD99, CTNND1 | TSPO 1545/4885NPY5R 4059/4885PTGES 4031/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.